Rapport Therapeutics, Inc. (RAPP)

32.38 -1.20 (-3.57%) USD  |  NASDAQ  |  Apr 06, 16:00
32.41 +0.03 (+0.09%) After-Hours: 20:00
More

Rapport Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for RAPP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
EyePoint Plc Upgrade
Praxis Precision Medicines, Inc. Upgrade
Bridgebio Oncology Therapeutics, Inc. --
Olema Pharmaceuticals, Inc. Upgrade
Arcellx, Inc. Upgrade